International Assets Investment Management LLC Acquires 13,439 Shares of Zoetis Inc. $ZTS

International Assets Investment Management LLC raised its position in Zoetis Inc. (NYSE:ZTS) by 204.8% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 20,000 shares of the company’s stock after buying an additional 13,439 shares during the quarter. International Assets Investment Management LLC’s holdings in Zoetis were worth $1,397,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of ZTS. Cassaday & Co Wealth Management LLC purchased a new stake in shares of Zoetis in the first quarter valued at approximately $28,000. Root Financial Partners LLC raised its position in Zoetis by 66.5% in the first quarter. Root Financial Partners LLC now owns 258 shares of the company’s stock worth $30,000 after acquiring an additional 103 shares in the last quarter. Wellington Grp LLC lifted its holdings in Zoetis by 6,675.0% in the first quarter. Wellington Grp LLC now owns 271 shares of the company’s stock valued at $32,000 after acquiring an additional 267 shares during the period. Global Assets Advisory LLC acquired a new stake in Zoetis in the first quarter valued at $38,000. Finally, University of Texas Texas AM Investment Management Co. purchased a new stake in shares of Zoetis during the 2nd quarter worth $25,000. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the stock. Piper Sandler cut their price target on shares of Zoetis from $90.00 to $80.00 and set a “neutral” rating for the company in a report on Monday, August 10th. Weiss Ratings raised shares of Zoetis from a “sell (d)” rating to a “sell (d+)” rating in a report on Thursday, October 29th. TD Cowen decreased their price objective on shares of Zoetis from $104.00 to $94.00 and set a “buy” rating on the stock in a report on Tuesday, August 25th. Cantor Fitzgerald set a $94.00 target price on shares of Zoetis in a research report on Tuesday, August 25th. Finally, Zacks Research raised Zoetis from a “strong sell” rating to a “hold” rating in a research note on Monday, October 26th. Six equities research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $93.79.

Zoetis Stock Up 0.0%

ZTS opened at $83.19 on Wednesday. The firm has a market cap of $34.38 billion, a P/E ratio of 12.64, a PEG ratio of 1.23 and a beta of 0.67. The business’s fifty day simple moving average is $75.27 and its 200 day simple moving average is $93.22. Zoetis Inc. has a 52 week low of $68.77 and a 52 week high of $132.49. The company has a quick ratio of 1.84, a current ratio of 3.08 and a debt-to-equity ratio of 2.87.

Zoetis (NYSE:ZTS) last announced its earnings results on Thursday, August 6th. The company reported $1.87 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.02. The firm had revenue of $2.47 billion during the quarter, compared to the consensus estimate of $2.50 billion. Zoetis had a net margin of 27.49% and a return on equity of 74.89%. The firm’s revenue for the quarter was down .2% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.76 EPS. Zoetis has set its FY 2026 guidance at 6.150-6.250 EPS. As a group, equities research analysts anticipate that Zoetis Inc. will post 6.15 EPS for the current fiscal year.

Zoetis Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 1st. Stockholders of record on Friday, October 30th will be given a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend is Friday, October 30th. Zoetis’s payout ratio is currently 34.93%.

Zoetis Company Profile

Zoetis Inc is a global animal health company that develops, manufactures and markets medicines, vaccines, diagnostics, genetic products and related services for animals. Its offerings support the prevention, diagnosis and treatment of disease in both companion animals, including dogs, cats and horses, and livestock such as cattle, swine, poultry and fish.

The company’s product portfolio includes prescription medicines, parasiticides, vaccines, veterinary diagnostics and animal genetics.